Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-024641
Filing Date
2026-05-20
Accepted
2026-05-20 16:51:47
Documents
82
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 1766558
2 EX-31.1 ex31-1.htm EX-31.1 20867
3 EX-32.1 ex32-1.htm EX-32.1 7412
4 GRAPHIC form10-k_001.jpg GRAPHIC 16246
5 GRAPHIC form10-k_002.jpg GRAPHIC 10273
  Complete submission text file 0001493152-26-024641.txt   10412268

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nphc-20251231.xsd EX-101.SCH 65856
7 XBRL CALCULATION FILE nphc-20251231_cal.xml EX-101.CAL 81658
8 XBRL DEFINITION FILE nphc-20251231_def.xml EX-101.DEF 303381
9 XBRL LABEL FILE nphc-20251231_lab.xml EX-101.LAB 567764
10 XBRL PRESENTATION FILE nphc-20251231_pre.xml EX-101.PRE 464795
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1447374
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32141 | Film No.: 261004785
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)